×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Bharat Parenterals Limited | NA | NA | NA | NA | 941.0 | 38.8 |
| KOPRAN LTD. | 531.32 | 35.18 | 513.35 | 0.73 | 889 | 25.4 |
| NGL FINE-CHEM LTD. | 1074.12 | 76.44 | 1008.58 | 12.37 | 879 | 42.1 |
Bharat Parenterals Limited, with Security Code 541096, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59.0 | 51.0 | 69.9 | 59.8 | 58.8 | 65.6 | 92.1 | 64.5 | 67.3 | 80.3 |
| Expenses | 55.5 | 44.4 | 58.4 | 53.4 | 52.0 | 61.9 | 77.1 | 58.8 | 59.0 | 75.6 |
| Operating Profit | 3.5 | 6.6 | 11.5 | 6.4 | 6.8 | 3.7 | 15.0 | 5.7 | 8.4 | 4.7 |
| OPM % | 5.91% | 12.93% | 16.44% | 10.75% | 11.53% | 5.7% | 16.28% | 8.78% | 12.4% | 5.83% |
| Other Income | 4.0 | 7.0 | 2.9 | 3.5 | 2.4 | 3.2 | 3.9 | 4.6 | 3.8 | 2.3 |
| Interest | 0.8 | 0.8 | 0.9 | 0.6 | 0.6 | 1.1 | 1.0 | 0.9 | 1.4 | 1.5 |
| Depreciation | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 | 1.9 | 1.8 |
| Profit before tax | 5.2 | 11.3 | 12.0 | 7.7 | 6.9 | 4.3 | 16.3 | 7.6 | 8.9 | 3.6 |
| Tax % | -27.2% | -17.8% | -25.7% | -27.5% | -26.5% | -31.1% | -25.1% | -28% | -26.7% | -30.9% |
| Net Profit | 3.8 | 9.3 | 8.9 | 5.6 | 5.1 | 3.1 | 12.2 | 5.5 | 6.5 | 2.3 |
| EPS in Rs | 6.6 | 16.19 | 15.4 | 9.62 | 8.65 | 5.15 | 20.26 | 7.9 | 8.3 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59.0 | 51.0 | 69.9 | 59.8 | 59.8 | 67.8 | 92.5 | 71.6 | 72.3 | 104.0 |
| Expenses | 56.4 | 44.8 | 59.5 | 55.5 | 53.2 | 66.8 | 88.0 | 79.3 | 68.6 | 101.7 |
| Operating Profit | 2.6 | 6.2 | 10.5 | 4.3 | 6.6 | 1.0 | 4.5 | -7.7 | 3.6 | 2.3 |
| OPM % | 4.47% | 12.2% | 14.95% | 7.22% | 11.07% | 1.46% | 4.85% | -10.71% | 5.04% | 2.23% |
| Other Income | 3.5 | 0.3 | 2.1 | 2.6 | 1.3 | 2.6 | 2.5 | 4.2 | 3.0 | 2.2 |
| Interest | 0.8 | 0.8 | 0.9 | 0.6 | 0.6 | 1.1 | 2.8 | 2.9 | 3.3 | 4.2 |
| Depreciation | 1.4 | 1.4 | 1.6 | 1.8 | 1.8 | 3.9 | 9.0 | 9.0 | 8.8 | 8.5 |
| Profit before tax | 3.9 | 4.3 | 10.1 | 4.5 | 5.5 | -1.4 | -4.8 | -15.4 | -5.5 | -8.2 |
| Tax % | -36.5% | -47% | -30.5% | -46.5% | -33.5% | 97.8% | 85.5% | 13.9% | 43.1% | 0% |
| Net Profit | 2.5 | 2.3 | 7.0 | 2.4 | 3.6 | -2.6 | -8.8 | -17.5 | -7.9 | -9.4 |
| EPS in Rs | 4.94 | 4.24 | 13.03 | 6.07 | 6.45 | -0.62 | -14.71 | -27 | -10 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 6% |
| 3 Years: | 13% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 0% |
| 3 Years: | 7% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 38% |
| 3 Years: | 48% |
| 1 Year: | -24% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 8% |
| 3 Years: | 17% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -219% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 38% |
| 3 Years: | 48% |
| 1 Year: | -24% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|